Phoenix Molecular Designs
Latest round
- Series A
Last raised
- Sep 2020
Total raised
- $12M
Investors
- 4
About Phoenix Molecular Designs
Phoenix Molecular Designs Ltd.Founded in 2012 and headquartered in Vancouver, Canada, Phoenix Molecular Designs Ltd. develops innovative cancer therapies.Phoenix Molecular Designs specializes in personalized cancer therapeutics with a strong emphasis on RSK (p90 ribosomal S6 kinase) inhibition. Their lead product, PMD-026, targets RSK2, a key player in breast cancer development and treatment resistance. The company is also developing a companion diagnostic to identify patients who will benefit from RSK-targeted therapies, ultimately improving patient outcomes.The revenue generation model for Phoenix Molecular Designs focuses on the commercialization of their patented cancer therapeutics and diagnostic tools, notably PMD-026. The company pursues direct-to-consumer sales and partnerships with healthcare providers and pharmaceutical firms to broaden distribution. Revenue arises from product sales and licensing agreements, which may involve upfront payments, milestone payments upon achieving development goals, and royalties on future sales. The company plans to expand its product line by launching new therapeutics that enhance cancer treatment efficacy, with specific release dates yet to be determined. Additionally, Phoenix Molecular Designs is targeting expansion into new markets within North America and Europe, aiming to capture the increasing demand for innovative oncology treatment options as it advances its research and development efforts.
Who invested in Phoenix Molecular Designs
4 investors across 4 rounds
See all investors in Phoenix Molecular Designs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phoenix Molecular Designs
Who invested in Phoenix Molecular Designs?
Phoenix Molecular Designs has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phoenix Molecular Designs raised?
Phoenix Molecular Designs has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Phoenix Molecular Designs last raise money?
Phoenix Molecular Designs's most recent round on record is a Series A, in Sep 2020.
What does Phoenix Molecular Designs do?
Phoenix Molecular Designs is a biotechnology company.
Where is Phoenix Molecular Designs headquartered?
Phoenix Molecular Designs is headquartered in Vancouver, Canada.
Which VCs invest in companies like Phoenix Molecular Designs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Phoenix Molecular Designs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Phoenix Molecular Designs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.